HCACX
Price
$26.07
Change
-$0.24 (-0.91%)
Updated
Jul 13 closing price
Net Assets
6.29B
VFFSX
Price
$367.80
Change
-$2.94 (-0.79%)
Updated
Jul 13 closing price
Net Assets
1.67T
Interact to see
Advertisement

HCACX vs VFFSX

HCACX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
HCACX vs. VFFSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCACX is a Buy and VFFSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.67T vs. HCACX (6.29B). VFFSX pays higher dividends than HCACX: VFFSX (1.08) vs HCACX (0.00). HCACX was incepted earlier than VFFSX: HCACX (28 years) vs VFFSX (10 years). HCACX (1.86) is less costly to investors than VFFSX (0.01). HCACX is a more actively managed with annual turnover of: 94.00 vs. VFFSX (2.00). HCACX has a lower initial minimum investment than VFFSX: HCACX (2000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 21.07 vs. HCACX (3.38). VFFSX return over 5 years is better than : 73.48 vs. HCACX (-20.11).
HCACXVFFSXHCACX / VFFSX
Total Expense Ratio1.860.0118,600%
Annual Report Gross Expense Ratio1.860.0118,600%
Fund Existence28 years10 years-
Gain YTD8.40510.68579%
Front LoadN/AN/A-
Min. Initial Investment200050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.29B1.67T0%
Annual Yield % from dividends0.001.08-
Returns for 1 year3.3821.0716%
Returns for 3 years12.8668.4519%
Returns for 5 years-20.1173.48-27%
Returns for 10 years-5.92251.21-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZIEX20.58N/A
N/A
Lazard International Equity Instl
CMNWX91.13N/A
N/A
Principal Capital Appreciation A
PRWCX38.43N/A
N/A
T. Rowe Price Capital Appreciation
TRZYX24.28N/A
N/A
T. Rowe Price Latin America Z
MCYSX16.25-0.50
-2.99%
NYLI Candriam Emerging Markets Eq Cl R6